$CLIR

ClearSign Announces Private Placement of $1,770,000

ClearSign Technologies (Nasdaq: CLIR) says it completed a private placement of 500,000 shares of common stock to an existing stockholder at $3.54 per share, raising $1.77 million gross. The company plans to use net proceeds for working capital, R&D, marketing and sales, and general corporate purposes.

Original reporting
Published Jul 23, 2026, 1:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 23, 2026, 1:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$CLIR
Neutral
medium confidence
Mentioned
$CLIR
Relevance
6/10
AlphAI data visualization · based on itnewsonline.com
Decision brief

The 30-second read

$CLIRNeutralMed
01

Why it matters

The disclosed financing provides $1.77M gross proceeds for working capital, R&D, marketing and sales, and general corporate purposes, but it also introduces dilution risk at a fixed issuance price.

02

Market read

Traders can reassess CLIR’s near-term float/dilution expectations and funding runway based on the completed placement terms and proceeds use.

03

What to watch

The article does not state whether the placement is dilutive relative to current share count, nor any lock-up/registration timeline, which can materially affect valuation and selling pressure.

Relevance 6/10Novelty 7/10Timing: after-hours/dated July 22 close of the private placement, reported July 23

Background

ClearSign Technologies announced and completed a private placement with an existing stockholder, priced off the average Nasdaq closing price for five trading days ending June 21, 2026.

Company-level read

Ticker impact

$CLIRNeutralMedium confidence
Context

ClearSign completed a private placement of 500,000 shares at $3.54 per share for $1.77M gross proceeds, closed July 22, 2026.

Expected impact

Near-term downside bias from dilution/financing optics, with stabilization if investors view proceeds as funding growth.

Evidence & confidence

The article discloses the placement size, price, gross proceeds, and intended use, but provides no incremental guidance or demand/oversubscription details.

Market effects

Adds another small-cap emissions/combustion technology issuer using equity financing, reinforcing funding sensitivity in the decarbonization theme.

No specific regional market linkage beyond Nasdaq-listed small-cap capital markets.

Limited global read-through; primarily affects ClearSign’s capital structure and near-term trading/liquidity.

Counterpoint

If the placement price is near recent trading levels and the holder is supportive, the market may treat it as routine funding rather than a distress signal.

Key entities

  • ClearSign Technologies Corporation

    Nasdaq-listed combustion and sensing technology company completing a $1.77M private placement.

  • Existing stockholder

    The investor purchasing 500,000 shares at $3.54 per share in the private placement.

  • Jim Deller, Ph.D.

    CEO who commented on the stockholder’s continued support.

Related articles

$CLIRLow

ClearSign Technologies Corp (CLIR): Results of Operations and Financial Condition

ClearSign Technologies Corp (CLIR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ClearSign Technologies Corporation Provides Second Quarter 2026 Update TULSA, Okla., August 19, 2026 – ClearSign Technologies Corporation (Nasdaq: CLIR) (“ClearSign” or the “Company”), a leader in advanced combustion and sensing technologies that help industrial oper

$CLIRMedAI 8/10

ClearSign (CLIR) Q4 2025 Earnings Transcript

ClearSign Technologies reported Q4 2025 revenue of $3.7 million versus $590,000 in Q4 2024, driven mainly by a 26-process burner order for a Gulf Coast petrochemical plant, according to CFO Brent Hinds. Full-year 2025 revenue rose 44% to $5.2 million. Gross margin was 27% (down from 31%) and the full-year net loss increased about $197,000, mainly from $746,000 in legal fees. Cash was $9.2 million.

$PHOSMed

First Phosphate shareholders could see reduced dilution risk, Noble says after SERV news

First Phosphate Corp. (PHOS) may face reduced equity dilution after Noble Capital Markets noted potential lower funding needs for its Bégin-Lamarche project, supported by Swiss Export Risk Insurance (SERV) and other financing. SERV could provide up to US$212.5 million, reducing the equity requirement to about US$82.5 million. Noble maintains an Outperform rating and $25.50 price target.

$AONHighAI 9/10

Aon raises $13.75 billion to support USI acquisition

Aon raised $13.75 billion in senior notes, guaranteed by its subsidiaries, with maturities from 2029 to 2056 and coupons ranging from 5.350% to 6.450%. The funds, approximately $13.4 billion after expenses, will support the USI Advantage Corp. acquisition and general corporate purposes. The notes include redemption protections tied to the deal's completion.